CN Patent

CN108314677B — 一种ezh2抑制剂及其用途

Assigned to Anhui Zhongke Tuotuo Pharmaceutical Science Research Co Ltd · Expires 2020-06-30 · 6y expired

What this patent protects

本发明涉及人组蛋白甲基转移酶EZH2的野生型和Y641F突变型的抑制剂，其具有式(I)的结构。本发明还提供使用该抑制剂治疗与EZH2活性相关的癌症或癌前病症的方法和用途。

USPTO Abstract

本发明涉及人组蛋白甲基转移酶EZH2的野生型和Y641F突变型的抑制剂，其具有式(I)的结构。本发明还提供使用该抑制剂治疗与EZH2活性相关的癌症或癌前病症的方法和用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN108314677B
Jurisdiction
CN
Classification
—
Expires
2020-06-30
Drug substance claim
No
Drug product claim
No
Assignee
Anhui Zhongke Tuotuo Pharmaceutical Science Research Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.